Delivery Order SPE2DB20D1100-SPE2DB25FA4F3

Award Date 2/3/25
Potential Completion Date 2/4/25
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $7,839.42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order type, with a firm fixed price, and covers the supply of NURTEC ODT 75 MG TABLET 8S medical products. The contract has an ultimate completion date of November 26, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $17,825.43, is a delivery order under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which is worth up to $999,999,999 and runs through November 2026. The contract covers the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, to support...
This federal contract award, valued at $11,844.07, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB20D1100|SPE2DB25FB0A4) with a firm fixed price pricing type. The award supports the delivery of NURTEC ODT 75 MG TABLET 8S to DLA, with a period of performance through March 10, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $19,050.75, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order without a set-aside designation, indicating open competition. The contract covers the supply of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, with a period of performance through October 31, 2023. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award, valued at $16,461.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of NURTEC ODT 75 MG TABLET 8S, a medical product, with an ultimate completion date of April 9, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation. AmerisourceBergen holds a significant...
This federal contract award, valued at $9,563.51, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is January 8, 2025. The contract covers the supply of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, to support federal healthcare programs. Amerisourcebergen holds a significant...
This federal contract award, valued at $22,247.95, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of NURTEC ODT 75 MG TABLET 8S, a prescription medication. The contract has a firm fixed price and an ultimate completion date of December 15, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $10,848.52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the product 'NURTEC ODT 75 MG TABLET 8S' and has a firm fixed price pricing type. The contract has an ultimate completion date of January 27, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is a $13,768.63 firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of NURTEC ODT 75 MG TABLET 8S, a prescription medication, with a performance period through December 10, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a vehicle for providing a broad range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,314.86, is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, worth up to $999,999,999 through November 2026. This IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FA4F3
    Delivery Order

This federal contract award, valued at $11,989.67, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, running through February 4, 2025. The award covers the procurement of NURTEC ODT 75 MG TABLET 8S, a medical product, for use by DLA and its supported medical facilities.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

The contract award did not include any set-aside designations, indicating open competition.

Generated 5/5/25, 9:52 AM